This HTML5 document contains 46 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n17http://linked.opendata.cz/resource/mesh/concept/
n18http://linked.opendata.cz/resource/drugbank/company/
n15http://linked.opendata.cz/resource/drugbank/drug/DB04817/identifier/wikipedia/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04817/identifier/pubchem-compound/
n6http://bio2rdf.org/drugbank:
n8http://linked.opendata.cz/resource/drugbank/drug/DB04817/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB04817/identifier/drugbank/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n16http://linked.opendata.cz/ontology/mesh/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB04817/identifier/chemspider/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04817/identifier/chebi/

Statements

Subject Item
n2:DB04817
rdf:type
n3:Drug
n3:description
Metamizole, formerly marketed as Dimethone tablets and injection, Protemp oral liquid, and other drug products, was associated with potentially fatal agranulocytosis. Approvals of the NDA's for dipyrone drug products were withdrawn on June 27, 1977 (see the Federal Register of June 17, 1977 (42 FR 30893)). Withdrawn from the Canadian market in 1963.
n3:group
withdrawn
n3:indication
Used in the past as a powerful painkiller and fever reducer.
owl:sameAs
n6:DB04817 n14:DB04817
dcterms:title
Metamizole
adms:identifier
n8:46509035 n9:DB04817 n10:522325 n11:25979 n13:6000 n15:Dipyrone
n3:packager
n18:271B563F-363D-11E5-9242-09173F13E4C5
n3:synonym
Dipyrone
n3:salt
n16:hasConcept
n17:M0006535
n3:IUPAC-Name
n4:271B5644-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B564A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5649-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5646-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5647-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5648-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5642-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5640-363D-11E5-9242-09173F13E4C5 n4:271B5643-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5641-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5650-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5651-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B564B-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B564C-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B564E-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B564D-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B564F-363D-11E5-9242-09173F13E4C5
n3:affectedOrganism
Humans and other mammals
n3:casRegistryNumber
50567-35-6
n3:category
n3:Bioavailability
n4:271B5656-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5658-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5659-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5655-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5654-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5657-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5645-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5652-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5653-363D-11E5-9242-09173F13E4C5